Tag: treatment for haemophilia B
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
AVEVA and Schneider Electric spearhead digital transformation in mining
AVEVA, a global leader in industrial software driving digital transformation, has partnered with Schneider Electric to redefine what smart, sustainable mining looks like in the age of AI.
